NIP
RXDX
Nicholas Investment Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-272,910
| Closed | -$29.3M | – | 217 |
|
|
2023
Q1 | $29.3M | Sell |
272,910
-10,336
| -4% | -$1.11M | 2.23% | 6 |
|
|
2022
Q4 | $31.2M | Sell |
283,246
-205,989
| -42% | -$22.7M | 2.73% | 1 |
|
|
2022
Q3 | $28.9M | Sell |
489,235
-42,058
| -8% | -$2.48M | 2.68% | 1 |
|
|
2022
Q2 | $15M | Buy |
531,293
+344,213
| +184% | +$9.72M | 1.42% | 18 |
|
|
2022
Q1 | $7.06M | Buy |
+187,080
| New | +$7.06M | 0.5% | 72 |
|